| Released | Contributor | Author | Title | Pages | Price |
| 30-Nov-2009 | New Constructs, LLC |
N/A
| NEXM: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 29-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 29-Nov-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for NexMed, Inc. | 42 |
$65 |
| 28-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: NEXMED INC | 5 |
$25 |
| 28-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| Nexmed Inc | 5 |
$25 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | NEXMED INC (NEXM=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | NEXMED INC (NEXM=US) 12-months forecast | 1 |
$15 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: NEXMED -- NEXM | 1 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ACUS , CORT , ELTP , NEXM , PRWP , RGN , SIGA , SYNI -- DRUGS | 3 |
$4 |
| 23-Nov-2009 | Thomson StreetEvents |
N/A
| NEXM - Event Transcript of NexMed conference call, Nov. 23, 2009 / 9:00am ET | 9 |
$75 |
1.48% Nasdaq 0.00%
Research Reports
